Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invyncible vs NewSelf

Invyncible
Graded #303

Lower grade

vs+24.599999999999994
NewSelf
Graded #18

Higher grade

The verdict

NewSelf takes it — 85.6/100 to 61/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNewSelf +38
55
93
Dose & formulationNewSelf +16
64
80
Clinical oversightNewSelf +14
70
84
Labs & monitoringNewSelf +30
52
82
FulfillmentNewSelf +22
65
87
Contract termsNewSelf +24
61
85
Invyncible · left barNewSelf · right bar

The numbers

MetricInvyncibleNewSelf
WeighScore61/10085.6/100
GradeCB
Scorecard rank#303#18
Semaglutide$192/mo (0.5 mg dose, compounded)$100/mo
Tirzepatide$210/mo (compounded)$144/mo
Coverage40 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly
NewSelf

Graded #18 · B

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard